当前位置:文档之家› 皮下植入式化疗泵导向给药联合扶正抑瘤方治疗结直肠癌的临床研究

皮下植入式化疗泵导向给药联合扶正抑瘤方治疗结直肠癌的临床研究

?606 ?现代中西医结合杂志Modern Journal of Integrated Traditional Chinese and Western Medic

皮下植入式化联合 抑瘤方治疗

结直肠癌的临床研究

孔利霞,孔军卫,赵天昌,王梅,王旭锋

(河北省武安市中医院,河北武安056300)

[摘要] 探讨微创皮下植入式化疗泵导向给药联合扶正抑瘤方

治疗中晚期结直肠癌的临床疗效。将60例中晚期结直肠癌患者随机

分为研究组和对照组各3 0例,研究组采用皮下植入式化疗泵导向给药联合扶

正抑瘤方治疗,对照组采用静脉化疗。21d为1个疗程,2组均治疗6个疗

程。统计2组近期疗效及不良反应发生情况,观察2组治疗前后肿瘤标志物

甲胎蛋白(A F P)、癌胚抗原(C E A)及白细胞计数情况。研究组近期总

有效率和控制率分别为63. 33%和80.00% ,对照组近期总有效率和控制率分 别为46.67%和60.00%,研究组近期疗效优于对照组(/><0.05)。2组治疗后入??^瓦入水平均显 著降低均<0.05),且研究组均明显低于对照组均<0. 05)。2组治疗后白细胞计数检均较 治疗前有所下降均<0.05),但研究组下降幅度小于对照组<0.05)。研究组不良反应发生 率明显低于对照组(P< 0.0 5)。皮下动脉植入化疗泵导向给药联合扶正抑瘤方治疗结直肠

癌患者近期疗效明显优于静脉化疗,且可增强患者免疫力,减轻化疗反应。

[关键词]化疗泵导向给药;扶正抑瘤方;结直肠癌

doi:10.3969/j.issn. 1008 -8849.2019.06.010

[中图分类号]R75.3[文献标识码]A[文章编号]1008 -884(019) 06 -0606 -04 Clinical study of subcutaneous implantable chemottierapy pum p- guided medication com bined

witli Fuzheng Yilin decoction in the treatment of colorectal cancer

K O N G Lixia,K O N G Junw ei,ZH AO Tianchang,W AN G Mei,W AN G X ufen g

(Wu’a n H ospital〇0T raditional C hinese M edicine,Wu’a n056300,Hebei,China)

Abstract:Objective It is to investigate th e clinical efficacy of m in im ally invasiv th erap y pum p-guided m ed ication com bin ed w ith Fuzheng Yiliu decoction o n advanced colorectal cancer.M tien ts w ith advanced colorectal cancer w ere ran d o m ly divided in to stu d y gro u p ad con trol group,30 cases in each group.

T h e stu d y g ro u p w as treated w ith subcutan eous im plantable chem otherapy p u m p - directed m ed ication com bin ed w ith

F uzheng Yiliu decoction.The con trol gro u p w as treated w ith in traven ou s chem otherapy. 21 days a

b o th gro u p s w ere treated for6courses.The sh o rt-term efects an d occurrence of adverse r

statistically analyzed.The tu m o r m arkers alpha-fetoprotein (AFP),carcinoem bry〇nic an tigen (CEA)a n d w h ite b lo od cell cou n t w ere observed before a n d after treatm en t.Results T h e recent to ta l effective ra te a n d con trol ra te of th e stu d y g ro u p

w ere63.33% a n d80.00%,respectively,th ose of th e con trol gro u p w ere46.67% an d60.00%,respectively.T he sh ort-te rm eficacy of th e stu d y gro u p w as better th an th at of th e con trol gro u p(P< 0.05). The levels of AFP an d CEA in th e

tw o gro u p s w ere significantly decreased after treatm en t(P<0. 05),an d th e levels in th e s er th a n th at in th e con trol gro u p(P<0. 05) .T he w h ite b lo od cell cou n ts of th e tw o gro u p s w ere low er th a n th o se b efo re treatm en t(P< 0.05),b u t th e decrease of th e stu d y gro u p w as less th an th at of th e con trol g ro u p(P< 0.05). The inci-dence of adverse reactions in th e stu d y g ro u p w as significantly low er th a n th a t in th e con trol gro u p(P< T h e sh o rt-term efect of su bcutaneous artery im p lan tation chem otherapy-guided m ed ication c coction is significantly b etter th a n in traven ou s chem otherapy in th e treatm en t of colorectal cancer patients,an d can en hance

th e patients im m u n ity a n d reduce th e chem otherapy response.

[作者简介]孔利霞,女,硕士,副主任医师,主要从事肛肠科临床工作。

相关主题
文本预览
相关文档 最新文档